chrisvoncsefalvay/vaers-outcomes huggingface dataset:
contracted COVID19 last month even though I was vaccinated; contracted COVID19 last month even though I was vaccinated; My Pain is greater than 10 ever since I contracted COVID19 last month even though I was vaccinated; This is a spontaneous report from a contactable Healthcare Professional and a consumer (patient). A 59-years-old female patient received BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine (dose number not provided), via an unspecified route of administration on an unspecified date, at 59 years of age, (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included essential primary hypertension, gastrooesophageal reflux disease without esophagitis, arthritis enteropathic and myositis, all from an unknown date. The patient was not pregnant at the time of the event. The patient's concomitant medications included tofacitinib citrate (XELJANZ) 11 mg tablet once daily from May2021 for Rheumatoid arthritis with rheumatoid factor. The patient reported she contracted COVID-19 the month before (Jun2021), even though she was vaccinated (number of doses unspecified), and her pain has been greater than 10 ever since when she contracted COVID-19 the month before (Jun2021). Her doctor has given her steroids pack to help. The outcome of the reported events was unknown at the time of the report.  Information on the lot/batch number has been requested.; Sender's Comments: The efficacy of a drug varies from patient to patient and can be affected by different factors; however, a contributory role of the suspect product BNT162B2 or comirnaty to the reported event drug ineffective and covid-19 cannot be ruled out.
Onset of daily urticaria and dermatographism which has persisted to time of medical encounter on 2/11/22
after receiving a dose of the Moderna vaccine (not booster), her implants became infected; This spontaneous case was reported by a consumer and describes the occurrence of DEVICE RELATED INFECTION (after receiving a dose of the Moderna vaccine (not booster), her implants became infected) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Breast implant user (had breast implants).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEVICE RELATED INFECTION (after receiving a dose of the Moderna vaccine (not booster), her implants became infected) (seriousness criterion medically significant). The patient was treated with Surgery (One implant need to be removed) for Device related infection. At the time of the report, DEVICE RELATED INFECTION (after receiving a dose of the Moderna vaccine (not booster), her implants became infected) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided by the reporter.  Company comment:  This case concerns a female patient with no relevant medical history who experienced serious unexpected event of device related infection, reported as breast implant infection, that occurred after the dose of the mRNA-1273 .  The rechallenge was not applicable due to unspecified number of doses administered. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a female patient with no relevant medical history who experienced serious unexpected event of device related infection, reported as breast implant infection, that occurred after the dose of the mRNA-1273 .  The rechallenge was not applicable due to unspecified number of doses administered. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Received HPV-9 approximately 10am at school based health center without incident. Finished school day and attended volleyball that afternoon. Mother report she came home tired and not feeling well. Next day attended school but that night had chills, nausea and vomited x 1. Fever to 102.4 degrees on 9/4/15 morning. Also with body aches and mild sore throat. 9/5 - some fever. Symptoms resolved by Sunday 9/6/15. Treated with TYLENOL and MOTRIN MOC concerned all reaction to the immunization and was reported. Denies problems with 2 previous HPV 4 vaccinations.
Felt dizzy but states she was "very emotional" about getting her shot. HX of anaphylaxis from IV contrast. HR 100, O2 98%, BP 175/100. Declined observation and drove home.
RT ARM SUBCUT WHERE VARICELLA WAS GIVEN HAD RAISED RED AREA OF 3MM X 3MM- WARM TO THE TOUCH. ADVISED COOL COMPRESSES, GIVE TYLENOL OR ADVIL - PT STATES THAT HIS RT ARM DOES NOT HAVE ANY ITCHING.
Area where vaccines given red, swollen, tender. No treatment. Symptoms worst on day of vaccine, better by next day.
After getting flu shot in left arm, client stated she had severe pain right away and that it hurt terrible. Before leaving the building. She felt her arm "stiffening and feeling weird". Pain radiated to shoulder down the elbow area.  Initially it was warm to touch.  She called her doctor and he said to take Tylenol, and use heat and to call him next week.
Information has been received from a physician concerning a 3 year old male pt who on approx. 6/13/00, was vaccinated with 1 dose of Hep-A virus vaccine inactivated. Approx. 4 days, post vax, the pt experienced a "skin reaction" characterized by a "general papular, erythematous rash". Unspecified medical attention was sought. Additional information has been requested.
"didn't feel so good"; "dizzy-ish"; "head felt real big"/weird head feeling"; left arm hurt; "real tired"; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE ("didn't feel so good"), DIZZINESS ("dizzy-ish"), HEAD DISCOMFORT ("head felt real big"/weird head feeling"), PAIN IN EXTREMITY (left arm hurt) and FATIGUE ("real tired") in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation. Concurrent medical conditions included Drug allergy (Allergic to Naproxen) and Allergy NOS. Concomitant products included DRONEDARONE HYDROCHLORIDE (MULTAQ) and ACETYLSALICYLIC ACID (ASPIRIN LOW) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced MALAISE ("didn't feel so good"), DIZZINESS ("dizzy-ish"), HEAD DISCOMFORT ("head felt real big"/weird head feeling"), PAIN IN EXTREMITY (left arm hurt) and FATIGUE ("real tired"). On 03-Mar-2021, MALAISE ("didn't feel so good"), DIZZINESS ("dizzy-ish"), HEAD DISCOMFORT ("head felt real big"/weird head feeling"), PAIN IN EXTREMITY (left arm hurt) and FATIGUE ("real tired") had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment Medications were not provided by the reporter.
Injection site was sore first couple of days(like someone punched me in the arm) then went away.  Last night the site is again sore, itchy, swollen and a slight rash has appeared
This spontaneous report as received from a health professional refers to a 9 week old patient of unknown gender. The pertinent medical history, allergic history and concomitant medications were unspecified. On 22-MAR-2016, the patient was vaccinated with one dose of improperly stored RECOMBIVAX HB (lot # L004754, Expiry: 10-NOV-2016) 0.5 ml, intramuscular in the right thigh. The vaccine was stored at a temperature of 32 F for 19 hours. There was no previous temperature excursion. No adverse event was reported. Additional information has been requested.
Loose Stools- similar to IBS or lactose intolerance. Can't narrow down to only dairy though.; This is a spontaneous report from a non-contactable nurse. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685) via an unspecified route of administration in the arm right on 08Jan2021 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history included sulfa allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included ZYRTEC, CELEXA, and WELLBUTRIN, all from unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 22Jan2021, the patient experienced loose stools which was similar to irritable bowel syndrome (IBS) or lactose intolerance. The patient reported that she could not narrow down to only dairy though. The adverse event did not result in doctor or other healthcare professional office/clinic and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event loose stools was not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
p/vax pt returned 12:15Pm w/wheezing/retractions/SOB;
Sore arm; Tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm"; FATIGUE (non-serious), outcome "unknown", described as "Tired".  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300352612 same patient, different dose/event;
First felt tingling feeling within first 24 hours after receiving the vaccine and then developed a cold sore Treated with Abreva. Took about 2 weeks to heal
In April/02, (exact date not provided), the vaccinee received his first injections of Twinrix. Later on the day of immunization, he experienced "extreme' redness at the injection site. The redness resolved the following day. The vaccine provider considered the event to be probably related to the neomycin sulfate included in the cell growth media used to produce Twinrix. The Twinrix immunization series was discontinued.
mom c/o rt leg swelling up p/vax this morning;no distint area of redness around inj site;mild amount of swelling gen on rt thith;mom states no high temp given advil 2PM;seen @ clinic;
PT. BEGAN FEELING LIGHT HEADED 15 MIN AFTER RECEIVING THE VACCINE HAD PT LAY DOWN WITH FEET ELEVATED BP 190/89, PT DENIES HTN, RETURNED TO LAY ON LT SIDE ALTERNATING AS PT. REQUESTED TO BACK AND THEN AGAIN TO LT. SIDE. CALLED AMBULANCE AT 4:15 AFTER BP 200/198.  AMBULANCE ARRIVED 4:20 AND BP THEN 200/100.  PT TRANSFERRED FROM BED TO EMS GURNEY WITH ASSISTANCE AFTER STANDING, PT. C/O FEELING WEAK AND TREMBLING. PT'S HUSBAND REPORTS THAT HTN MEDS HAVEN'T BEEN TAKEN IN ABOUT 8 MONTHS AFTER PT. CHECKING BP AT HOME HAS BEEN GOOD. HUSBAND REPORTS PT HAD POSSIBLY GOTTEN UPSET AFTER BEING CONVINCED TO TAKE THE COVID VACCINE. HUSBAND THINKS SHE
Patient describes "usual" arm muscle soreness for 4 days following flu shot, but also felt unusually fatigued. Arm muscle soreness went away after four days, only to return, then get progressively worse. She reported this perceived vaccine injury on 10/28/08.
Red raised lesion on the injection site; Lesion is itchy; This spontaneous case was reported by a consumer and describes the occurrence of SKIN LESION (Red raised lesion on the injection site) and PRURITUS (Lesion is itchy) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced SKIN LESION (Red raised lesion on the injection site) and PRURITUS (Lesion is itchy). At the time of the report, SKIN LESION (Red raised lesion on the injection site) and PRURITUS (Lesion is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information included alcohol application on the lesion.  No concomitant medication was provided.
48 hours after receiving immunizations, child's left thigh was red, swollen, itchy; no fever. Was seen in ER and diagnosed with cellulitis. Started on oral antibiotics and seen 2 days alter. Swelling, redness had totally resolved.
Intussusception.  Reoccurred after initial enema.  Required operative repair with bowel resection.  First Rotateq vaccine given at 13 wks of age on 8/21/07.  12/11/2007 Vax record received and corresponds to data on VAERS submission. 12/26/2007 MR received for DOS 11/26-30/2007 with D/C DX: Intussusception (ileocolic). Infant presented to ER with 24 hr hx of nausea, vomiting and abdominal pain.  Pt had currant jelly/bloody BM.  Air contrast enema reduction initially successful but recurred. 2nd attempt only partially successful after 3 attempts.  Taken to OR for Exploratory Lap with attempted reduction of intussuscpeption; ileal and R colon resection with anastomosis. D/C on POD3#.
pt says she has swollen area by breast and underarm. a little painful. pt is taking motrin to help with pain/inflammation.
Patient given Comvax, Prevnar, MMR, Varivax. Developed 100.2 temp approximately 3 hours later, then some hives around hip/upper thigh. Given Benadryl and Tylenol. About 10 hours later, developed temp 102 ---> 104 had 2-3 minute seizure; taken to hosp by EMS.
Case number PHHY2011US107075 is an initial literature report received on 06 Dec 2011: The authors presented a case of multiple sclerosis after vaccination with a rabies vaccine. This report refers to a 21-year-old male patient. He was vaccinated with three doses of Purified chick embryo cell rabies vaccine (manufacturer and batch number: unknown therefore conservatively taken as RABAVERT INN) on undetermined dates. 10 days after the final dose, he developed stabbing pains in his left wrist. Two days later, this progressed to numbness in his right hand and right posterior neck. He also had daily headaches, urinary urgency, frequency and incomplete emptying, and his family reported cognitive changes. Ten days after symptom onset, brain MRI revealed more than 30 enhancing lesions, with notable involvement of the left temporal lobe, the area near the corpus callosum and the cerebellum. An MRI of the cervical spine showed more than 10 enhancing lesions, and there were ten CSF oligoclonal bands. A diagnosis of acute disseminated encephalomyelitis was suspected. He received methylprednisolone with limited improvement of his symptoms. Follow-up imaging studies at two months revealed new enhancing lesions, and multiple sclerosis was diagnosed. He started receiving interferon beta-1a and, after six months of treatment, he had one relapse. The authors commented that a close temporal relationship and the fulminant onset of disease suggested a causative role for the vaccine.
Pt c/o redness, swelling and itching to immunization administration site (R) deltoid that started 9/24/13 (the evening of administration). Pt also c/o headache and lightheadedness. Pt denies nausea, vomiting. Pt is afebrile.
Early this morning, woke with chills & cold. Put on socks, another shirt, added bedding, and slept fitfully yet warm. I arose with headache, muscle soreness, mild stomach upset & mild nausea. NO fever. This is the first hours after waking, self reporting vs. waiting for Monday when I might forget this even happened.
On the day of the shot the leg around the area of the DTaP became red and swollen. No fever or any other symptoms noted. The next day the leg looked the same and the second day the are around the site had a red rash half moon shape. The center where the injection occurred was normal in color and size. After 24 Hours, everything went away and  the leg looked normal, according to mother. She states she did not take the child to the doctor's  but Iexplained she should discuss having the DT's for #4 in the series of DTaP
flu; Initial information received on 07-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involves patient (unknown demographics) who experienced flu (influenza), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) unknown latency following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for influenza.  There will be no information available on the batch number for this case.
Mother called 2/24/04 (AM) and reported child was lethargic and listless. Mother denies fever. Baby ate well. Mother doesn't have a doctor for baby. Has appointment scheduled in one week later. Advised mother to seek medical help today. Call placed to mother at 2 PM; reveal baby hospitalized for possible meningitis. Medical records state lymphoma, asthasia, asthenia. msv  Nurse follow up on 08/19/04 states: "Fever; irritable;
Pt recv vax on 5/8/97; on 10/28/98 pt exp 8 lesions on back, neck, buttocks, chest, eyelid.
Chills 12 hrs after injection while asleep, , subsided by morning.   Swollen lymph node under arm, left side
Had Td on 10/8/03 - exercised arm by swimming and playing volleyball. On 10/9/03 arm began to swell from right deltoid across shoulder to neck and left shoulder. Also area is very painful.
Bumps on palms of hands and fingers that are sore Rash on tops of both hands Started on 4-9-2021 and persist yet on 4-15-2021
pt recvd vax 11AM & leg started swelling during noc; no temp; leg from knee to groin swollen-unable to walk; area 2" around site very red;
Local reaction (swelling, warmth, tenderness) <24 hr after vaccination. Tx with warm packs, TYLENOL
As of today, 7/19/02, I have broken out with a rash of chicken pox over my body.  My main concern is according to people I spoke with today at the CDC, my 4 week old infant is in danger of catching the chicken pox from me as I have blisters/pox on my breasts and am breast-feeding her.  According to the person I spoke with at the CDC, the chicken pox is "very dangererous" for her.  I am extremely upset that I was not advised to wait until she had been vaccinated at 12 months of age before I had this vaccine myself.  I now have to wait 2-3 weeks in fear to see if she breaks out with the chicken pox.
Patient is a 61 yom who presents to the emergency department with shortness of breath.  The patient complains of diarrhea, decreased by mouth intake, cough, shortness of breath, myalgias, along with loss of taste and smell.  The patient reports he was tested for COVID-19 last week and does not know the results.  In our system he has a positive COVID test from 09/10 and 9/11. On presentation to the emergency room he was hypoxic with oxygen saturation of 90% on 3 L nasal cannula. Chest x-ray showing bilateral basal infiltrates.  Hospital Course   61-year-old male with  history of HIV, DM admitted for acute hypoxic respiratory failure secondary to COVID.   # Acute hypoxic respiratory failure secondary to COVID 19 pneumonia.  Initially presented with hypoxia on 3 L of oxygen but require support with high-flow nasal cannula. Was able to be weaned off the high-flow nasal cannula and is currently on 4 L.. Has completed 6 days of dexamethasone and 5 days of IV remdesivir.  The Has improved clinically and inflammatory markers have been trending down CT PE 9/15:  No pulmonary embolism. Multiple scattered left greater than right lower lobe predominant groundglass opacities with bibasilar dependent atelectasis, consistent with atypical viral infection.  Plan -discharged home on home oxygen -continue additional 4 more days of dexamethasone -albuterol inhaler as needed -the Health Department to contact him for further instructions on quarantine matters
Projectile vomiting.  Continued to dry-heave after emptying stomach contents.  Continued to dry-heave/have muscle spasms every 10 minutes for the following 30 minutes.
11 doses were given from a 10 dose vial with no reported adverse event; Initial information received on 03-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves patient of unknown age and gender and it was reported that 11 doses were given from a 10 dose vial of ipv (vero) [Ipol] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect ipv (vero) (formulation: Suspension for injection) (strength; lot number; expiry date not reported) via unknown route in unknown administration site for immunization.  On an unknown date 11 doses were given from a 10-dose vial of ipv (vero) with no reported adverse event (incorrect dose administered) (latency: same day).  It was reported, "10 dose vial, would the 11th dose be considered a valid dose? If not valid, would it need to be repeated?"  Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
It was reported that a pt (3 of 3) received a Tripedia vaccination, date not specified. Reportedly, sometime after the vaccination, the pt developed a local reaction. Further information is requested. Per telephone conversation with LPN on 3/27/01, it was reported that 3 of 3 received Tripedia in unit dose form. Apparently, pt 3 of 3 had a "little erythema". Physician chose not to complete VAERS form for pt 3 of 3. Request further information. From additional correspondence received on 4/16/01, no new information was provided.
Pt recvd 3 doses Engerix-B, 3rd given 15MAR91; About 6 hrs p/3rd inject pt exp itching, swelling @ site, erythema 6in diameter, lt palm red, itching, swollen, throat itching & hives on lt thigh & local induration; Pt went to ER & tx DPH;